[ad_1] Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection, prognosis & treatment, perhaps even a #PrecisionMedicine approach like #gene therapy someday: #eyes #glaucoma #Ophthalmology #biotech https://t.co/1REz7x85tQ [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Honored to present on Suprachoroidal Drug Delivery & Clearside’s preclinical and clinical research programs at the rece… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Honored to be listed here and thankful for those patients, colleagues & mentors who inspire us… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Pleased to work with Vestrum on clinical data analytics… https://t.co/4uIFiCI2NM [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Recently published on a leading cause of #vision loss. #Diabetic macular edema treatment burden remains a significant… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Our study highlighted in @RetinalPhys – #Suprachoroidal delivery is of interest given #clinicaltrials of corticosteroid… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: For COVID-19, mRNA vaccines have sprinted to approval. Historically, #retina played an important role in #RNA #therapy… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.